KCT0009272尚未招募Unknown
Efficacy of prophylactic potassium-competitive acid blockers after catheter ablation for atrial fibrillation
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19(Year) 至 90(Year)（—）
- 性别
- All
入选标准
- •i) Underwent radiofrequency ablation or cryoballoon ablation for atrial fibrillation.
- •ii) Age 19 to 90 years inclusive.
排除标准
- •i) Patients with moderate or severe liver impairment, or renal impairment (Serum Cr > 1.5 mg/dl).
- •ii) Patients with cognitive impairments that make it difficult to understand the study.
- •iii) Pregnant or breastfeeding patients, or those not willing to maintain contraception during the study period.
- •iv) Patients with hypersensitivity to fexuprazan, or those with galactose intolerance, lactase deficiency, or glucose-galactose malabsorption.
- •v) Patients taking contraindicated medications such as atazanavir, nelfinavir, or rilpivirine.
- •vi) Patients who have taken Proton Pump Inhibitors (PPI) or PCAB agents for gastroesophageal reflux disease within 2 weeks prior to study enrollment.
- •vii) Other patients for whom the clinical administration of PCAB is considered difficult.
研究者
相似试验
尚未招募
2 期
Efficacy of Vonoprazan in Management of Post Endoscopic Variceal Ligation UlcerDigestive SystemPACTR202207793488326General Organization for Teaching Hospitals and Institutes300
尚未招募
不适用
Study of the improvement effect of potassium competitive acid blocker and proton pump inhibitors on symptoms in patients with gastro-esophageal reflux disease (GERD): a randomized comparative study of vonoprazan 20mg vs. rabeprazole 10mg using the time (number of days) to improvement in symptoms as an indexgastro-esophageal reflux disease (GERD)JPRN-UMIN000021621Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan100
招募中
3 期
The effect of potassium citrate and double j stent in reducing stone formatiorinary stones.Calculus of kidney with calculus of ureterN20.2IRCT20190624043991N8Tehran University of Medical Sciences70
尚未招募
不适用
Study of the improvement effect of potassium competitive acid blocker and proton pump inhibitors on symptoms in patients with reflux esophagitis (RE): a randomized comparative study of vonoprazan 20mg vs. rabeprazole 10mg using the time (number of days) to improvement in symptoms as an indexpatients with reflux esophagitisJPRN-UMIN000016637Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan100
进行中（未招募）
不适用
Impact assessment of potassium competitive acid blocker on the gut microbiota of Anginal patientsKCT0008181Kangwon National University Hospital40